Scopus Chosen by Leading Australian Institutes
Helping researchers answer the Research Quality Framework requirements set by the government
Amsterdam – April 25, 2007 –Scopus®, the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research, today announced that two of Australia’s most prestigious institutes have chosen the database for its comprehensive content coverage and its ability to serve as a research performance measurement tool. The University of New South Wales and Monash University are the first of the Group of Eight to embrace Scopus.
"We are proud of our broad range and high quality research facilities," said Alison Neil, Manager, Vendor Services & Finance, The University of New South Wales, "And we are pleased that we can now include Scopus in our offering. Its unrivaled content coverage will allow our administrators, faculty, and students to search and evaluate global as well as local peer-reviewed journals from Australia and New Zealand."
Another factor driving the universities’ decision to adopt Scopus is its bearing on the Research Quality Framework (RQF) which will be mandatory in 2008. Ms. Suzanne Clarke, Director of the Monash University Library Information Resources Division, points out that, "Scopus will enable researchers to demonstrate the impact of their own publications by identifying citations to their work in the 15,000 titles indexed in Scopus. Such quantitative data is of growing importance due to the government's Research Quality Framework and the emphasis it places on such indicators when assessing the quality and impact of research. We expect that Scopus will become an integral tool for many of our users."
"Scopus is providing these esteemed Australian institutes with the tools and features they need to maintain their position as leading research facilities," said Jaco Zijlstra, Scopus Director. "We are proud that these institutes have decided to join many others in the region who already capitalize on their investment in Scopus."
# # #
Covering the world’s research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research. Scopus is designed and developed with over 300 users and librarians internationally. Its unique database contains abstracts and references from over 15,000 peer reviewed journals from 4,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also integrates web & patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool.
For more information about Scopus please visit www.info.scopus.com.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact:
Fusion Public Relations
T: +1 202 898 2000, ext. 117